Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 10 Neoplasms 9 Breast Neoplasms 9 Colorectal Neoplasms 8 Lung Neoplasms 5 Papillomavirus Infections 3 Uterine Cervical Dysplasia 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Heart Diseases 2 HIV Infections 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 End Stage Liver Disease 2 the Rate of Participation in Screening for PBC 1 Warts 1 Venous Thromboembolism 1 Uterine Cervical Diseases 1 Urinary Bladder Neoplasms 1 Tinea 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Skin Neoplasms 1 Retinoblastoma 1 Radiation Injuries 1 Pulmonary Atelectasis 1 Postural Orthostatic Tachycardia Syndrome 1 Postoperative Complications 1

Interventions

Therapeutics 31 Psychiatric Rehabilitation 27 Surveys and Questionnaires 15 Cognitive Behavioral Therapy 12 Early Intervention, Educational 10 Psilocybin 9 Ketamine 9 Methods 8 Saline Solution 7 Yoga 6 Mindfulness-Based Cognitive Therapy 6 Interviews as Topic 6 Esketamine 6 Counseling 6 Psychosocial Intervention 5 Mindfulness 5 Methylphenidate 5 Escitalopram 5 Educational Status 5 Behavior Therapy 5 Acupuncture Therapy 5 Palliative Care 4 Exercise Therapy 4 Exercise 4 Control Groups 4 Caregivers 4 Standard of Care 3 Psychotherapy 3 Niacin 3 Mindfulness-Based Stress Reduction 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Depression × Mass Screening × Clear all

NCT02273206 2020-03-12

PCM3

Clinical Directors Network

Phase NA Completed

802 enrolled 28 charts

Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡